Compare ABVX & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | ARE |
|---|---|---|
| Founded | 2013 | 1994 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.8B |
| IPO Year | N/A | 1997 |
| Metric | ABVX | ARE |
|---|---|---|
| Price | $114.15 | $53.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 10 |
| Target Price | ★ $118.33 | $62.75 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 08-11-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 8.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,231,374.00 | ★ $3,058,395,000.00 |
| Revenue This Year | $6.80 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.77 | $44.10 |
| 52 Week High | $148.83 | $105.14 |
| Indicator | ABVX | ARE |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 62.51 |
| Support Level | $116.20 | $48.10 |
| Resistance Level | $129.56 | $50.08 |
| Average True Range (ATR) | 7.87 | 1.37 |
| MACD | -2.47 | 0.96 |
| Stochastic Oscillator | 15.05 | 91.34 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.